Literature DB >> 26503080

Paravalvular leak after transcatheter aortic valve implantation (TAVI): Short-term results. Data from Polish national POL-TAVI registry.

Paweł Kleczyński1, Wojciech Zasada, Maciej Bagieński, Łukasz Rzeszutko, Danuta Sorysz, Robert Sobczyński, Jarosław Trębacz, Bogdan Kapelak, Marian Zembala, Dariusz Dudek.   

Abstract

BACKGROUND: The authors analyzed data from Polish national POL-TAVI registry in terms of paravalvular leak (PVL) occurrence after transcatheter aortic valve implantation (TAVI) and its impact on clinical outcomes.
METHODS: A total of 331 patients with severe aortic stenosis underwent TAVI (Edwards Sapien, n = 141; CoreValve, n = 190). The grade of PVL and survival rate were assessed at6-month follow-up.
RESULTS: One hundred and eighty-one (54.7%) patients developed mild PVL, and 22 (6.6%) - moderate PVL after TAVI. No severe PVLs were observed. Occurrence of moderate PVL was device dependent and more frequent in the CoreValve group (p = 0.02). Larger CoreValve device used correlated with the grade of PVL (Spearman: r = 0.19; p = 0.01), but for Edwards Sapien devices this correlation was inverted (Spearman: r = -0.62; p = 0.01). Six-month mortality rate was not significant between patients with no or mild PVL compared to those with moderate PVL (p = 0.12).
CONCLUSIONS: The PVL occurrence remains a frequent problem after TAVI and is device de-pendent, more common with Edwards 23 mm valve and 31 mm CoreValve prosthesis.

Entities:  

Keywords:  TAVI; aortic stenosis; high-risk patients; paravalvular leak

Mesh:

Year:  2015        PMID: 26503080     DOI: 10.5603/CJ.a2015.0071

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  6 in total

1.  Transcatheter aortic valve implantation improves carotid and vertebral arterial blood flow in patients with severe aortic stenosis: practical role of orthostatic stress test.

Authors:  Pawel Kleczyński; Pawel Petkow Dimitrow; Artur Dziewierz; Andrzej Surdacki; Dariusz Dudek
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

2.  Paravalvular leak prediction after transcatheter aortic valve replacement with self-expandable prosthesis based on quantitative aortic calcification analysis.

Authors:  Agata Wiktorowicz; Adrian Wit; Krzysztof Piotr Malinowski; Artur Dziewierz; Lukasz Rzeszutko; Dariusz Dudek; Pawel Kleczynski
Journal:  Quant Imaging Med Surg       Date:  2021-02

3.  Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry.

Authors:  Maciej Bagienski; Pawel Kleczynski; Artur Dziewierz; Lukasz Rzeszutko; Danuta Sorysz; Jaroslaw Trebacz; Robert Sobczynski; Marek Tomala; Maciej Stapor; Andrzej Gackowski; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-05-11       Impact factor: 1.426

4.  POL-TAVI - Polish Registry of Transcatheter Aortic Valve Implantation - simple tool, great value, rationale and design.

Authors:  Joanna Zembala-John; Krzysztof Wilczek; Zdzisław Tobota; Piotr Chodór; Daniel Cieśla; Tomasz Jaźwiec; Waldemar Banasiak; Janina Stępińska; Zbigniew Kalarus; Grzegorz Opolski; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-12-30

5.  Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis.

Authors:  Łukasz Wiewiórka; Robert Sobczyński; Jarosław Trębacz; Jerzy Sadowski; Dariusz Dudek; Maciej Stąpór; Janusz Konstanty-Kalandyk; Robert Musiał; Andrzej Gackowski; Krzystof Malinowski; Paweł Kleczyński; Krzysztof Żmudka; Bogusław Kapelak; Jacek Legutko
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

6.  Quantitative estimation of aortic valve calcification in multislice computed tomography in predicting the development of paravalvular leaks following transcatheter aortic valve replacement.

Authors:  Małgorzata Ryś; Tomasz Hryniewiecki; Ilona Michałowska; Patrycjusz Stokłosa; Monika Różewicz-Juraszek; Zbigniew Chmielak; Maciej Dąbrowski; Kryspin Mirota; Piotr Szymański
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.